Poland – Pharmaceutical products – Supply of medicinal products

Opportunity description

The subject of the contract is the supply of medicinal products: medicines for the implementation of drug programmes, medicines from the chemotherapy catalogue, various medicines including those from the reimbursement list, immunoglobulins, diagnostic tests, sterile gel, products for securing central venous access catheters, dialysis concentrates, medicines authorised for marketing with the consent of the Minister of Health, products for nutritional treatment, haemostatic dressing, buffered formalin, with the possibility of submitting partial tenders for packages Nos. 1-89, in accordance with the breakdown in the price form constituting Annex No. 3 to the SWZ. 1 Amivantamabum solution for injection, 1600 mg 1 vial 10 ml pkg. 56 2 Amivantamabum solution for injection, 2240 mg, 1 vial 14 ml pkg. 56 3 Amivantamabum concentrate for solution for infusion, 350 mg 1 vial 7 ml pkg. 214 The Contracting Authority requires the offering of a medicinal product used in drug programme B.6 Lazertinib film-coated tablets, 240 mg 28 pcs. pkg. 52 The Contracting Authority requires the offering of a medicinal product used in drug programme B.6 Atezolizumabum solution for injection, 1875 mg 1 vial of 15 ml pkg. 252 The Contracting Authority requires the offering of a medicinal product used in drug programme B.6 Glecaprevirum + Pibrentasvirum film-coated tablets 100 mg + 40 mg x 84 pcs. pkg. 15 The Contracting Authority requires the offering of a medicinal product used in drug programme B.71 1 Tucatinibum, film-coated tablets, 50 mg x 88 pcs. pkg. 15 2 Tucatinibum, film-coated tablets, 150 mg x 84 pcs. pkg. 15 The Contracting Authority requires a medicinal product used in drug programme B.9 Tezepelumabum, solution for injection in a pen, 210 mg 1 pen containing 1.91 ml pkg. 120 The Contracting Authority requires a medicinal product used in drug programme B.44 Dabrafenibum hard capsules, 75 mg x 120 pcs. pkg. 13 The Contracting Authority requires the offering of a product used in drug programme B59. Trametinibum film-coated tablets, 2 mg x 30 pcs. pkg. 13 The Contracting Authority requires the offering of a product used in drug programme B59. Sotorasibum 240 mg x 120 pcs., film-coated tablets pkg. 14 The Contracting Authority requires the offering of a product used in drug programme B6. Lorlatynibum 100 mg x 30 pcs., film-coated tablets pkg. 14 The Contracting Authority requires the offering of a product used in drug programme B6 Darbepoetinum alfa 40 mcg/0.4 ml solution for injection x 1 pre-filled syringe 0.4 ml ] pkg. 24 The Contracting Authority requires the offering of a product used in drug programme B37 1 Nintedanibum 100 mg x 60 capsules pkg. 40 2 Nintedanibum 150 mg x 60 capsules pkg. 200 The Contracting Authority requires the offering of a product used in drug programme B 135 1 Apalutamidum film-coated tablets, 60 mg x 120 pcs. pkg. 60 2 Apalutamidum film-coated tablets, 240 mg x 30 pcs. pkg. 30 The Contracting Authority requires the offering of a product used in drug programme B56 1 Alirocumabum solution for injection 150 mg x 2 pens pkg. 60 2 Alirocumabum solution for injection 300 mg x 1 pen pkg. 350 The Contracting Authority requires medicinal products in the package to be offered from one manufacturer. The Contracting Authority requires the offering of a product used in drug programme B 101 Amino acid ketoanalogues 630 mg x 100 film-coated tablets pkg. 1 200 The Contracting Authority requires the offering of a product used in drug programme B 113 Ocrelizumabum concentrate for solution for infusion, 30 mg/ml 10 ml pkg. 150 The Contracting Authority requires the offering of a product used in drug programme B 29 Glatirameri acetas 40 mg/ml solution for injection x 12 pre-filled syringes pkg. 30 The Contracting Authority requires the offering of products used in drug programme B.29. Epoprostenol, powder for solution for infusion, 1.5 mg x 1 vial pkg. 650 The Contracting Authority requires the offering of products used in drug programme B.31. Macitentanum, film-coated tablets, 10 mg x 30 pcs. pkg. 400 The Contracting Authority requires the offering of products used in drug programme B.31. Fingolimodum 0.5 mg x 28 hard capsules pkg. 35 The Contracting Authority requires the offering of products used in drug programme B.29. Iloprost 20 mcg/ml nebuliser solution x 42 ampoules 1 ml pkg. 52 The Contracting Authority requires the offering of products used in drug programme B.31. . Interferon beta 1a solution for intramuscular injection 30 µg/0.5 ml x 4 pens and solution for injection, 30 μg/0.5 ml 4 pre-filled syringes + 4 needles depending on the Contracting Authority’s needs pkg. 250 The Contracting Authority requires the offering of products used in drug programme B.29. The Contracting Authority requires the offering of a product administered once a week. Interferonum beta-1b, powder and solvent for solution for injection, 300 μg x 15 sets pkg. 35 The Contracting Authority requires the offering of products used in drug programme B.29. 1 Vedolizumabum solution for injection, 108 mg/0.68 ml x 2 syringes 40 2 Vedolizumabum powder for concentrate for solution for infusion, 300 mg x 1 vial of powder pkg. 70 The Contracting Authority requires the offering of products used in drug programmes B.32 and B.55 1 Ozanimodum hard capsules (0.23 mg + 0.46 mg) x 7 pcs. (4 pcs. of 0.23 mg + 3 pcs. of 0.46 mg) pkg. 5 2 Ozanimodum hard capsules of 0.92 mg x 28 pcs. pkg. 160 The Contracting Authority requires the offering of products used in drug programme B.29. Lanadelumabum solution for injection, 300 mg x 1 pre-filled syringe and a pen depending on the Contracting Authority’s needs pkg. 120 The Contracting Authority requires the offering of products used in drug programme B.122 Omalizumabum, solution for injection 150 mg x 1 pc. pkg. 600 The Contracting Authority requires the offering of products used in drug programmes B.107 and B.44 Trastuzumabum, powder for concentrate for solution for infusion, 420 mg x 1 vial pkg. 20 The Contracting Authority requires the offering of a product from the chemotherapy catalogue. Bicalutamidum 50 mg x x28 film-coated tablets pkg. 250 The Contracting Authority requires the offering of a product from the chemotherapy catalogue. 1 Doxorubicini hydrochloridum concentrate for solution for infusion 50 mg vial 210 2 Doxorubicini hydrochloridum concentrate for solution for infusion 100 mg vial 190 3 Doxorubicini hydrochloridum concentrate for solution for infusion 200 mg vial 115 The Contracting Authority requires the offering of a product from the chemotherapy catalogue. The Contracting Authority requires medicinal products in the package to be offered from one manufacturer in order to combine doses. The Contracting Authority requires stability of the undiluted concentrate drawn from the vial after puncture for min. 72 h, 1 Oxaliplatinum concentrate for solution for infusion 50 mg vial 750 2 Oxaliplatinum concentrate for solution for infusion 100 mg vial 10 3 Oxaliplatinum concentrate for solution for infusion 200 mg vial 200 The Contracting Authority requires medicinal products in the package to be offered from one manufacturer in order to combine doses. The Contracting Authority requires the offering of products from the chemotherapy catalogue. 1 Irinotecanum concentrate for solution for infusion 40 mg vial 5 2 Irinotecanum concentrate for solution for infusion 100 mg vial 230 3 Irinotecanum concentrate for solution for infusion 300 mg vial 380 4 Irinotecanum concentrate for solution for infusion 500 mg, vial 5 The Contracting Authority requires medicinal products in the package to be offered from one manufacturer in order to combine doses. The Contracting Authority requires the offering of products from the chemotherapy catalogue. Mesnum solution for injection 400 mg/4 ml x 15 ampoules pkg. 20 The Contracting Authority requires the offering of products from the chemotherapy catalogue. Dexamethasoni phosphas solution for injection 4 mg/ml x 5 ampoules pkg. 1 500 The Contracting Authority requires the offering of products from the chemotherapy catalogue. 1 Cyclophosphamidum, concentrate for solution for injection/infusion, 500 mg/5 ml vial 80 2 Cyclophosphamidum, concentrate for solution for injection/infusion, 1000 mg/10 ml vial 140 3 Cyclophosphamidum, concentrate for solution for injection/infusion, 2000 mg/20 ml vial 160 The Contracting Authority requires medicinal products in the package to be offered from one manufacturer in order to combine doses. The Contracting Authority requires the offering of products from the chemotherapy catalogue. Pegfilgrastimum solution for injection in a pre-filled syringe, 6 mg/0.6 ml pkg. 100 The Contracting Authority requires the offering of products from the chemotherapy catalogue. Vinblastine 1 mg/1 ml x 1 vial pkg. 50 Various medicines - 23 items Phenobarbital 100 mg/2 ml x 5 vials The Contracting Authority requires the offering of a product indicated for use in neonates pkg. 40 Landiololi hydrochloridum 300 mg powder for solution for infusion vial 450 Tenecteplasum, powder and solvent for solution for injection, 5000 IU vial 100 Fibrinogenum humanum powder and solvent for solution for injection and infusion 1 g pkg. 40 1 Oseltamivir capsules 30 mg x 10 pcs. pkg. 400 2 Oseltamivir capsules 45 mg x 10 pcs. pkg. 170 3 Oseltamivir capsules 75 mg x 10 pcs. pkg. 1 000 Gentamicinum inj. i.v. i.m. 0.08 g/2 ml x 10 ampoules pkg. 250 1 "Ferricum derisomaltosum 100 mg Fe3+/ml, for injection and infusion x 5 ampoules 1 ml The Contracting Authority permits Ferri hydroxidum dextranum/saccharum 50 mg Fe3+/ml 5 ampoules 2 ml" pkg. 80 2 Ferricum derisomaltosum 100 mg Fe3+/ml, for injection and infusion x 5 vials 5 ml pkg. 1 000 1 Bupivacain 0.5% 10 ml x 10 ampoules pkg. 400 2 Bupivacain 0.5% 20 ml x 5 vials pkg. 90 3 Ropivacaini hydrochloridum 10 mg/ml 10 ml x 5 ampoules pkg. 220 4 Ropivacainum inj. 5 mg/ml 10 ml 5 ampoules. For intrathecal administration pkg. 200 1 Acetylcysteine 0.3/3 ml x 5 ampoules pkg. 7 000 2 Acetylcysteine 0.6 x 10 effervescent tablets pkg. 1 400 1 Eptifibatide solution for injection 0.075/100 ml vial 10 2 Eptifibatide solution for injection 0.02 mg/10 ml vial 10 3 Milrinonum 1 mg/ml, solution for injection and infusion 10 vials of 10 ml pkg. 10 4 Naloxone 0.0004/ml x 10 ampoules pkg. 150 5 Testosteroni enantas 100 mg/ml, solution for injection x 5 ampoules pkg. 10 6 Thiopental inj. 0.5 g x 10 vials pkg. 150 Heparin inj. 25,000 IU/5 ml x 10 ampoules pkg. 750 1 Clarithromycin 0.5 x 14 film-coated tablets pkg. 600 2 Clarithromycin 0.25 x 14 film-coated tablets pkg. 200 3 Clarithromycin 0.5 inj. vial 5 000 4 Levofloxacinum 250 mg x 10 tablets pkg. 30 5 Levofloxacinum 500 mg x 10 tablets pkg. 300 6 Tigecycline 50 mg x 10 vials pkg. 70 Various medicines - 11 items 1 Ceftazidimum + Avibactamum 2 g + 0.5 g powder for concentrate for solution for infusion x 10 vials pkg. 90 2 Colistimethate sodium powder for preparation of solution for intravenous and intramuscular injection 1 million IU x 20 vials pkg. 350 1 Methylthionine chloride inj. 5 mg/ml x 5 ampoules of 2 ml pkg. 25 2 Methylthionine chloride inj. 5 mg/ml x 5 ampoules of 10 ml pkg. 15 1 Central vascular access catheter lock solution containing taurolidine 4% citrate, urokinase 25 000 units/ml x 5 ampoules of 5 ml pkg. 10 2 Central vascular access catheter lock solution containing taurolidine 4% sodium citrate, heparin sodium 500 IU/ml x 10 ampoules of 5 ml pkg. 70 3 Central vascular access catheter lock solution containing taurolidine 4% sodium citrate, heparin sodium 100 IU/ml x 10 ampoules of 3 ml pkg. 100 Fosfomycinum powder for solution for infusion of 4 g x 10 bottles pkg. 147 Linezolidum 2 mg/ml 300 ml solution for infusion x 1 bag/bottle pcs. 4 000 Meropenemum 1.0 g powder for solution for injection x 10 vials solution stability up to 24 h at 2-8 degrees C pkg. 1 200 1 Vancomycinum 1 g lyophilisate for solution for intravenous injection x 10 vials pkg. 1 200 2 Vancomycinum 500 mg powder for solution for infusion x 10 vials The Contracting Authority requires both doses to have registered indications for oral administration pkg. 500 1 Benzylpenicillin kalium inj. 3 million IU vial 100 2 Benzylpenicillin kalium inj. 5 million IU vial 2 000 3 Benzylpenicillin kalium inj. 1 million IU vial 100 1 Cefotaximum 1 g powder for solution for injection and infusion vial 13 000 2 Cefotaximum 2 g powder for solution for injection and infusion vial 7 000 1 Ceftriaxonum inj. 2 g dry substance x 1 vial vial 32 000 2 Ceftriaxonum inj. 1 g dry substance x 1 vial vial 27 000 1 Immunoglobulinum humanum IgG + IgM inj. i.v. solution 5% at a dose of 0.5 g/10 ml ad usum intravenosum pkg. 60 2 Immunoglobulinum humanum IgG + IgM inj. i.v. solution 5% (in doses of 2.5 g, 5 g depending on the Contracting Authority’s needs) g 100 3 Immunoglobulinum humanum IgG of 1 g/20 ml ad usum intravenosum pkg. 120 1 Amiodarone 0.2 x 30 tablets pkg. 200 2 Amiodarone hydrochloride solution for injection 150 mg/3 ml x 5 ampoules pkg. 800 3 Clopidogrel 300 mg x 30 film-coated tablets pkg. 50 4 Insulin Lispro Sanofi 300 IU/3 ml Solostar x 10 pens pkg. 25 5 Insulin Glargine -Toujeo 450 IU/1.5 ml x 10 pens pkg. 20 6 Insulin glulisine 300 IU/3 ml x 5 Solostar-type pens pkg. 15 7 Insulin glargine 300 IU/3 ml x 5 Solostar-type pens pkg. 25 8 Natrii polistyreni sulfonas of 454 g pkg. 55 9 Ramiprilum 0.005 x 28 tablets pkg. 1 200 10 Ramiprilum 0.01 x 28 tablets pkg. 300 Insulins under the above trade names are necessary to continue the treatment of patients already taking specific insulins Indocyanine Green powder for solution for injection 25 mg/5 ml x 5 vials pkg. 40 1 Etamsylate 0.25 x 30 tablets pkg. 440 2 Etamsylate 0.25/2 ml 12.5% x 50 ampoules pkg. 1 100 Calcium gluconate 9.5%-10% 10 ml x 5 ampoules pkg. 400 1 Metoprololum inj. 1 mg/ml 5 ml x 5 ampoules pkg. 500 2 Glyceryl trinitrate inj. 0.01/10 ml x 10 ampoules pkg. 200 Various medicines - 26 items 1 Torasemide 0.01 x 30 tablets pkg. 1 600 2. Torasemide 0.2 x 20 tablets pkg. 35 3. Torasemide 0.02 x 30 tablets pkg. 5 4. Torasemide 5 mg/ml of 4 ml x 5 ampoules pkg. 700 5. Prasugrel 10 mg x 28 film-coated tablets pkg. 20 6. Zofenopril 30 mg x 28 film-coated tablets pkg. 30 7. Zofenopril 7.5 mg x 28 film-coated tablets pkg. 50 1 Bisoprololum + Perindopirlum (5 mg + 5 mg) x 30 film-coated tablets pkg. 5 2 Bisoprololum + Perindopirlum (10 mg + 5 mg) x 30 film-coated tablets pkg. 5 3 Bisoprololum + Perindopirlum (5 mg + 10 mg) x 30 film-coated tablets pkg. 5 4 Bisoprololum + Perindopirlum (10 mg + 10 mg) x 30 film-coated tablets pkg. 5 5 Perindoprilum + Indapamidum + Amlodipinum (5 mg + 1.25 mg + 5 mg) x 90 film-coated tablets pkg. 30 6 Perindoprilum + Indapamidum + Amlodipinum (5 mg + 1.25 mg + 10 mg) x 30 film-coated tablets pkg. 10 7 Perindoprilum + Indapamidum + Amlodipinum (10 mg + 2.5 mg + 5 mg) x 90 film-coated tablets pkg. 10 8 Perindoprilum + Indapamidum + Amlodipinum (10 mg + 2.5 mg + 10 mg) x 90 film-coated tablets pkg. 10 9 Indapamidum + Amlodipinum (1.5 mg + 5 mg) x 30 modified-release tablets pkg. 3 10 Indapamidum + Amlodipinum (1.5 mg + 10 mg) x 90 modified-release tablets pkg. 3 Potassium 15% 20 ml x 20 vials/ampoules pkg. 800 Idarucyzumab 2.5 g/50 ml x 2 vials pkg. 6 1 Amantadine i.v. 0.2 G/500 ml x 10 bottles pkg. 20 2 Ornithine 5 g/10 ml x 10 ampoules pkg. 1 200 Norepinephrine 0.004/4 ml x 5 ampoules concentrate for solution for infusion pkg. 5 200 Pantoprazole inj. 0.04 x 1 vial pkg. 35 000 1 Multivitamin preparation containing per 900-1000 mg: Vitamin A, D3, E, K1, C, B1, B2, B6, B12, folic acid, pantothenic acid, biotin, nicotinamide. Powder for solution for infusion x 10 vials pkg. 8 2 Preparation of 9 trace elements with Fe II for parenteral nutrition x 5 glass ampoules pkg. 130 1 Preparation of 9 trace elements with Fe III for parenteral nutrition x 20 plastic ampoules pkg. 100 2 Organic phosphates of 20 ml for parenteral nutrition x 10 vials pkg. 50 1 Rapid test for detection of group A Streptococcus antigen. Package x 20 tests pkg. 25 2 Rapid antigen test for the qualitative, differential detection of SARS-CoV-2, Influenza A, Influenza B, RSV in nasal swab specimens. Package contents: test cassette, tube with buffer, sample collection swab, instructions for use, control material for each batch of tests. Package of 20 pkg. 700 3 Rapid test for semi-quantitative determination of C-reactive protein CRP x 10 pcs. pkg. 80 1 Methylergometrin inj. 0.2 mg/ml x 5 ampoules pkg. 5 2 Fenoterol inj. 0.025 mg/ml x 5 ampoules pkg. 10 3 Verapamil inj. 5 mg/2 ml x 5 ampoules pkg. 35 4 Sulprostone 0.5 mg/2 ml x 3 ampoules pkg. 25 Sterile gel containing ACP (auto-crosslinked polysaccharide) for preventing adhesions following surgical procedures in the abdominal and pelvic areas. Package: 10 ml syringe containing 30 mg ACP + application cannula, length 30 cm. pkg. 120 1 Acid concentrate for bicarbonate haemodialysis in proportions of 1+34, capacity 4.7 l. Calcium and potassium ion content depending on the Contracting Authority’s needs canister/bag 120 2 Dry sodium bicarbonate for haemodialysis 650 g pcs. 120 3 Dry sodium bicarbonate for haemodialysis 760 g pcs. 5 4 Dry sodium bicarbonate for haemodialysis 1100 g pcs. 5 Products must be compatible with the AK 98 renal replacement therapy machine 1 "Sterile, pyrogen-free three-chamber bag consisting of 50% glucose solution 80 ml, paediatric 5.9% amino acid solution with electrolytes 160 ml and 12.5% lipid emulsion 60 ml. Package of 10 bags, 300 ml" pkg. 10 2 "Sterile, pyrogen-free three-chamber bag consisting of 50% glucose solution 155 ml, paediatric 5.9% amino acid solution with electrolytes 221 ml and 12.5% lipid emulsion 124 ml. Package of 6 bags, 500 ml" pkg. 1 3 Multivitamin preparation of 750 g (water- and fat-soluble vitamins: Vitamin A, D3, E, C, B1, B2, B6, B12, PP, folic acid, pantothenic acid, biotin, powder for solution for injection and infusion x 10 vials pkg. 170 1 Absorbable haemostatic surgical dressing (combination of fibrin sealant and collagen mesh) 9.5 x 4.8 x 0.5 cm x 1 pc. pkg. 650 2 Absorbable haemostatic surgical dressing (combination of fibrin sealant and collagen mesh) 4.8 x 4.8 x 0.5 cm x 2 pcs. pkg. 250 3 Absorbable haemostatic surgical dressing (combination of fibrin sealant and collagen mesh) 4.8 x 4.8 x 0.5 cm x 1 pc. (rolled) pkg. 5 4 Absorbable haemostatic surgical dressing (combination of fibrin sealant and collagen mesh) 3.0 x 2.5 x 0.5 cm x 1 pc. pkg. 5 "Quadrivalent influenza vaccine (split virion), inactivated. Season 2026/27 The Contracting Authority permits a trivalent vaccine covering the three strains A/Victoria/4897/2022 (H1N1)pdm09-like virus; A/Croatia/10136RV/2023 (H3N2)-like virus; B/Austria/1359417/2021 (B/Victoria lineage)-like virus, season 2026/27" dose 200 Phenylephrini hydrochloridum 10 mg/ml x 10 ampoules pkg. 40 1 Progesteronum 200 mg, soft vaginal capsules x 15 pcs. pkg. 30 2 Sodium zirconium cyclosilicate 5 g, powder for oral suspension x 30 sachets pkg. 10 1 Palivizumabum, solution for injection, 100 mg/ml, vial 0.5 ml pkg. 50 2 Palivizumabum, solution for injection, 100 mg/ml, vial 1 ml pkg. 60 The Contracting Authority requires a medicinal product used in drug programme B 40 Roxadustatum film-coated tablets 20 mg x 12 pcs. pkg. 40 The Contracting Authority requires a medicinal product used in drug programme B 37 10% buffered formalin, intended for fixation of tissue material, pkg. 5 l, ready to use, in vitro diagnostic medical device, CE pkg. 120 Procedure: open. Review the original TED notice for the complete requirement, lots, amendments and attachments.